Literature DB >> 8679605

Human 25-hydroxyvitamin D3-24-hydroxylase, a multicatalytic enzyme.

M J Beckman1, P Tadikonda, E Werner, J Prahl, S Yamada, H F DeLuca.   

Abstract

Human 25-hydroxyvitamin D-24-hydroxylase has been expressed in Spodoptera frugiperda (Sf21) insect cells using the previously cloned cDNA in baculovirus (AcNPV-P450cc24). The activity of recombinant h-P450cc24 required adrenodoxin, adrenodoxin reductase, and NADPH. Incubation of this reconstituted system with 25-OH-[26,27-(3)H]D3 substrate produced several metabolites that were resolved on a normal-phase cyano HPLC system. These products exactly comigrated with authentic standards for 24-oxo-25-OH-D3, 23(S),25-(OH)2D3, 24(R),25-(OH)2D3, and 24-oxo-23(S),25-(OH)2D3. The soluble proteins from Sf21 cells infected with wild-type baculovirus produced neither 24,25-(OH)2D3 nor any of the other 25-OH-D3 metabolites. The products were isolated and subjected to a normal-phase amino HPLC for further separation, purification, and characterization. Comigration on two HPLC systems, periodate cleavage reactions, and NaBH4 reduction established clearly the identity of these metabolites. Incubation of recombinant h-P450cc24 with 25-OH-[3 alpha-3H]D3 led to the isolation of an additional product that comigrated with 24,25,26,27-tetranor-23-OH-D3. Treatment of putative 24,25,26,27-tetranor-23-OH-[3 alpha-3H]D3 with acetic anhydride changed its migration on amino HPLC to a less polar position, indicating acetylation of a hydroxyl group(s). These data demonstrate conclusively that h-P450cc24 is a multicatalytic enzyme catalyzing most, if not all, of the reactions in the C-24/C-23 pathway of 25-OH-D3 metabolism. It is likely that this enzyme by itself converts 25-OH-D3 and 1,25-(OH)2D3 to one of its final excretion products.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8679605     DOI: 10.1021/bi960658i

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  42 in total

Review 1.  Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism.

Authors:  L Darryl Quarles
Journal:  Nat Rev Endocrinol       Date:  2012-01-17       Impact factor: 43.330

2.  Epigenetic regulation of vitamin D 24-hydroxylase/CYP24A1 in human prostate cancer.

Authors:  Wei Luo; Adam R Karpf; Kristin K Deeb; Josephia R Muindi; Carl D Morrison; Candace S Johnson; Donald L Trump
Journal:  Cancer Res       Date:  2010-06-29       Impact factor: 12.701

3.  Metabolism of 20-hydroxyvitamin D3 and 20,23-dihydroxyvitamin D3 by rat and human CYP24A1.

Authors:  Elaine W Tieu; Wei Li; Jianjun Chen; Tae-Kang Kim; Dejian Ma; Andrzej T Slominski; Robert C Tuckey
Journal:  J Steroid Biochem Mol Biol       Date:  2015-02-26       Impact factor: 4.292

4.  Hybrid homology modeling and mutational analysis of cytochrome P450C24A1 (CYP24A1) of the Vitamin D pathway: insights into substrate specificity and membrane bound structure-function.

Authors:  Andrew J Annalora; Ekaterina Bobrovnikov-Marjon; Rita Serda; Andrzej Pastuszyn; Sandra E Graham; Craig B Marcus; John L Omdahl
Journal:  Arch Biochem Biophys       Date:  2006-12-03       Impact factor: 4.013

5.  Single A326G mutation converts human CYP24A1 from 25-OH-D3-24-hydroxylase into -23-hydroxylase, generating 1alpha,25-(OH)2D3-26,23-lactone.

Authors:  David E Prosser; Martin Kaufmann; Brendan O'Leary; Valarie Byford; Glenville Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-23       Impact factor: 11.205

Review 6.  Vitamin D signaling and melanoma: role of vitamin D and its receptors in melanoma progression and management.

Authors:  Andrzej T Slominski; Anna A Brożyna; Michal A Zmijewski; Wojciech Jóźwicki; Anton M Jetten; Rebecca S Mason; Robert C Tuckey; Craig A Elmets
Journal:  Lab Invest       Date:  2017-02-20       Impact factor: 5.662

7.  1,25-Dihydroxyvitamin D3 in the pathogenesis and treatment of osteoporosis.

Authors:  H F DeLuca
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

Review 8.  Formation and Cleavage of C-C Bonds by Enzymatic Oxidation-Reduction Reactions.

Authors:  F Peter Guengerich; Francis K Yoshimoto
Journal:  Chem Rev       Date:  2018-06-22       Impact factor: 60.622

Review 9.  Endogenously produced nonclassical vitamin D hydroxy-metabolites act as "biased" agonists on VDR and inverse agonists on RORα and RORγ.

Authors:  Andrzej T Slominski; Tae-Kang Kim; Judith V Hobrath; Allen S W Oak; Edith K Y Tang; Elaine W Tieu; Wei Li; Robert C Tuckey; Anton M Jetten
Journal:  J Steroid Biochem Mol Biol       Date:  2016-09-28       Impact factor: 4.292

10.  Chronic kidney disease and diabetes mellitus predict resistance to vitamin D replacement therapy.

Authors:  Hala M Alshayeb; Barry M Wall; Arif Showkat; L Darryl Quarles; Therese Mangold
Journal:  Am J Med Sci       Date:  2013-04       Impact factor: 2.378

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.